Would you consider radiotherapy for a pediatric patient with chemorefractory localized histiocytic sarcoma in the absence of the potential for surgical clearance?

If so, how would you sequence therapy and how would you balance the risk of acute and late effects with disease control in choosing the radiotherapy dose and fractionation.